Last $66.80 USD
Change Today -0.41 / -0.61%
Volume 2.4M
As of 4:15 PM 11/20/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John C. Lechleiter Ph.D.

Chairman, Chief Executive Officer and President, Eli Lilly and Company
AgeTotal Calculated CompensationThis person is connected to 62 board members in 6 different organizations across 4 different industries.

See Board Relationships
60$11,217,000
As of Fiscal Year 2013

Background*

Dr. John C. Lechleiter, Ph.D., has been President and Chief Executive Officer at Eli Lilly and Company since April 2008. Dr. Lechleiter serves as a Treasurer at Pharmaceutical Research and Manufacturers of America. He served as the President and Chief Operating Officer of Eli Lilly and Company, beginning in 2005. Since 2004, he served as an Executive Vice President for Pharmaceutical Operations at Eli Lilly and Company. Prior to that, he served as an Executive Vice President ...

Read Full Background

Corporate Headquarters*

Lilly Corporate Center
Indianapolis, Indiana 46285

United States

Phone: 317-276-2000
Fax: --

Board Members Memberships*

Treasurer and Director
Director
Director
1999-N/A
Former Director, Member of Audit Committee and Member of Compensation and Incentive Committee
2005-Present
Chairman, Chief Executive Officer and President
2009-Present
Independent Director, Member of Compensation Committee and Member of Corporate Responsibility & Sustainability Committee
2013-Present
Director

Education*

Doctorate
Harvard University
Master's Degree
Harvard University
BS 1975
Xavier University
Honorary Doctorate 2006
Marian University

Other Affiliations*

Annual Compensation*

Salary$1,500,000
Total Annual Compensation$1,500,000

Stock Options*

Restricted Stock Awards$6,750,000
All Other Compensation$90,000
Exercisable Options468,775
Total Number of Options468,775

Total Compensation*

Total Annual Cash Compensation$4,467,000
Total Short Term Compensation$1,500,000
Other Long Term Compensation$6,840,000
Total Calculated Compensation$11,217,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LLY:US $66.80 USD -0.41

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
Erez Vigodman Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELI LILLY & CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.